The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variant (2022)

First Author: Hogan A

Attributed to: Centre for Global Infectious Disease Analysis, Imperial College London (GIDA) - COVID-19 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.01.17.22269222

Publication URI: http://dx.doi.org/10.1101/2022.01.17.22269222

Type: Preprint